PIN20 A COST BENEFIT ANALYSIS OF ANTI-RETROVIRAL (ARVS) DRUGS IN THE TREATMENT OF HIV IN UGANDA
May 1, 2011, 00:00
10.1016/j.jval.2011.02.651
https://www.valueinhealthjournal.com/article/S1098-3015(11)00790-X/fulltext
Title :
PIN20 A COST BENEFIT ANALYSIS OF ANTI-RETROVIRAL (ARVS) DRUGS IN THE TREATMENT OF HIV IN UGANDA
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(11)00790-X&doi=10.1016/j.jval.2011.02.651
First page :
A117
Section Title :
Disease-Specific Studies
Open access? :
No
Section Order :
108